• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病中的精选细胞因子和金属蛋白酶。

Selected Cytokines and Metalloproteinases in Inflammatory Bowel Disease.

机构信息

Department of Internal Medicine, Angiology and Physical Medicine, Center for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, Batorego 15 Street, 41-902 Bytom, Poland.

Department of Photomedicine and Physical Chemistry, Medical College, University of Rzeszów, 35-959 Rzeszów, Poland.

出版信息

Int J Mol Sci. 2023 Dec 22;25(1):202. doi: 10.3390/ijms25010202.

DOI:10.3390/ijms25010202
PMID:38203373
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10779120/
Abstract

Inflammatory bowel disease (IBD) is a collective term for two diseases: ulcerative colitis (UC) and Crohn's disease (CD). There are many factors, e.g., genetic, environmental and immunological, that increase the likelihood of these diseases. Indicators of IBDs include extracellular matrix metalloproteinases (MMPs). The aim of this review is to present data on the role of selected cytokines and metalloproteinases in IBD. In recent years, more and more transcriptomic studies are emerging. These studies are improving the characterization of the cytokine microenvironment inside inflamed tissue. It is observed that the levels of several cytokines are consistently increased in inflamed tissue in IBD, both in UC and CD. This review shows that MMPs play a major role in the pathology of inflammatory processes, cancer, and IBD. IBD-associated inflammation is associated with increased expression of MMPs and reduced ability of tissue inhibitors of metalloproteinases (TIMPs) to inhibit their action. In IBD patients in tissues that are inflamed, MMPs are produced in excess and TIMP activity is not sufficient to block MMPs. This review is based on our personal selection of the literature that was retrieved by a selective search in PubMed using the terms "Inflammatory bowel disease" and "pathogenesis of Inflammatory bowel diseases" that includes systematic reviews, meta-analyses, and clinical trials. The involvement of the immune system in the pathophysiology of IBD is reviewed in terms of the role of the cytokines and metalloproteinases involved.

摘要

炎症性肠病(IBD)是两种疾病的统称:溃疡性结肠炎(UC)和克罗恩病(CD)。有许多因素,例如遗传、环境和免疫,会增加这些疾病的可能性。IBD 的指标包括细胞外基质金属蛋白酶(MMPs)。本综述的目的是介绍选定细胞因子和金属蛋白酶在 IBD 中的作用的数据。近年来,越来越多的转录组学研究正在涌现。这些研究正在改善对炎症组织内细胞因子微环境的特征描述。观察到在 IBD 中,无论是在 UC 还是 CD 中,炎症组织中几种细胞因子的水平都持续增加。本综述表明 MMPs 在炎症过程、癌症和 IBD 的病理学中起主要作用。与 IBD 相关的炎症与 MMPs 的表达增加以及组织金属蛋白酶抑制剂(TIMPs)抑制其作用的能力降低有关。在炎症组织中的 IBD 患者中,MMPs 过度产生,而 TIMP 活性不足以阻止 MMPs。本综述是基于我们个人选择的文献,这些文献是通过在 PubMed 中使用“炎症性肠病”和“炎症性肠病的发病机制”等术语进行选择性搜索检索到的,包括系统评价、荟萃分析和临床试验。本文综述了免疫系统在 IBD 病理生理学中的作用,涉及到参与的细胞因子和金属蛋白酶。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/10779120/c1586c2556bd/ijms-25-00202-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/10779120/6f581e32393c/ijms-25-00202-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/10779120/d4567bf73230/ijms-25-00202-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/10779120/98cadafa4412/ijms-25-00202-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/10779120/67695fe8a6f7/ijms-25-00202-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/10779120/c1586c2556bd/ijms-25-00202-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/10779120/6f581e32393c/ijms-25-00202-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/10779120/d4567bf73230/ijms-25-00202-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/10779120/98cadafa4412/ijms-25-00202-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/10779120/67695fe8a6f7/ijms-25-00202-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/10779120/c1586c2556bd/ijms-25-00202-g005.jpg

相似文献

1
Selected Cytokines and Metalloproteinases in Inflammatory Bowel Disease.炎症性肠病中的精选细胞因子和金属蛋白酶。
Int J Mol Sci. 2023 Dec 22;25(1):202. doi: 10.3390/ijms25010202.
2
The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases.基质金属蛋白酶及其组织抑制剂在炎症性肠病中的作用。
Dig Dis. 2012;30(3):289-95. doi: 10.1159/000336995. Epub 2012 Jun 20.
3
Metalloproteinases in Inflammatory Bowel Diseases.炎症性肠病中的金属蛋白酶
J Inflamm Res. 2021 Mar 23;14:1029-1041. doi: 10.2147/JIR.S288280. eCollection 2021.
4
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.用于研究正常和炎症状态下人结肠上皮细胞代谢与免疫功能的体外模型的开发、验证及应用
Dan Med J. 2015 Jan;62(1):B4973.
5
Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease.炎症性肠病患者结肠黏膜中基质金属蛋白酶及其组织抑制剂的差异表达
Gut. 2000 Jul;47(1):63-73. doi: 10.1136/gut.47.1.63.
6
Expression profiles of matrix metalloproteinases and their inhibitors in colonic inflammation related to pediatric inflammatory bowel disease.基质金属蛋白酶及其抑制剂在小儿炎症性肠病相关结肠炎症中的表达谱
Scand J Gastroenterol. 2010 Aug;45(7-8):862-71. doi: 10.3109/00365520903583863.
7
How to place the duality of specific MMP-9 inhibition for treatment of inflammatory bowel diseases into clinical opportunities?如何将特异性 MMP-9 抑制的双重性转化为治疗炎症性肠病的临床机会?
Front Immunol. 2022 Sep 9;13:983964. doi: 10.3389/fimmu.2022.983964. eCollection 2022.
8
Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis.对炎症性肠病结肠黏膜的全基因组基因表达荟萃分析表明,克罗恩病和溃疡性结肠炎之间没有主要差异。
PLoS One. 2013;8(2):e56818. doi: 10.1371/journal.pone.0056818. Epub 2013 Feb 13.
9
Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease.炎症性肠病患者血清中金属蛋白酶组织抑制剂(TIMP)-1和-4水平失衡。
BMC Gastroenterol. 2008 Nov 26;8:55. doi: 10.1186/1471-230X-8-55.
10
Chemokine and cytokine levels in inflammatory bowel disease patients.炎症性肠病患者体内趋化因子和细胞因子水平
Cytokine. 2016 Jan;77:44-9. doi: 10.1016/j.cyto.2015.10.008. Epub 2015 Oct 29.

引用本文的文献

1
DCLK1 isoform (DCLK1-S) as a critical player in promoting inflammation, tissue remodeling, and EMT in mouse models of colitis.DCLK1 异构体(DCLK1-S)在促进结肠炎小鼠模型中的炎症、组织重塑和上皮-间质转化过程中起关键作用。
PLoS Pathog. 2025 Aug 21;21(8):e1013360. doi: 10.1371/journal.ppat.1013360. eCollection 2025 Aug.
2
Immune Microenvironment Characterization and Machine Learning-Guided Identification of Diagnostic Biomarkers for Ulcerative Colitis.溃疡性结肠炎的免疫微环境特征及基于机器学习的诊断生物标志物识别
J Inflamm Res. 2025 Jul 9;18:8977-8992. doi: 10.2147/JIR.S526325. eCollection 2025.
3
A comparative pharmacological study of three Chinese traditional medicines found to be the key functional bacterium of Franch. and Cortex against colitis.

本文引用的文献

1
Identification of Novel Core Genes Involved in Malignant Transformation of Inflamed Colon Tissue Using a Computational Biology Approach and Verification in Murine Models.利用计算生物学方法鉴定炎症性结肠组织恶性转化中的新型核心基因,并在小鼠模型中验证。
Int J Mol Sci. 2023 Feb 21;24(5):4311. doi: 10.3390/ijms24054311.
2
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis.美国胃肠病学会关于生物标志物在溃疡性结肠炎管理中作用的临床实践指南。
Gastroenterology. 2023 Mar;164(3):344-372. doi: 10.1053/j.gastro.2022.12.007.
3
Identification of gene signatures associated with ulcerative colitis and the association with immune infiltrates in colon cancer.
一项对三种被发现是黄连和黄柏治疗结肠炎关键功能菌的中药的比较药理学研究。
Front Pharmacol. 2025 Jun 18;16:1587119. doi: 10.3389/fphar.2025.1587119. eCollection 2025.
4
Unveiling the hidden dance: SPP1 + macrophages identified in ulcerative colitis reveal crosstalk with CHI3L1 + fibroblasts.揭开隐藏的相互作用:在溃疡性结肠炎中鉴定出的SPP1 +巨噬细胞揭示了与CHI3L1 +成纤维细胞的相互作用。
J Transl Med. 2025 May 21;23(1):567. doi: 10.1186/s12967-025-06565-5.
5
Downregulation of MT2-MMP and MT5-MMP in ulcerative colitis serves a diagnostic predictor and potential therapeutic targets.溃疡性结肠炎中MT2-MMP和MT5-MMP的下调作为诊断预测指标和潜在治疗靶点。
Mol Biol Rep. 2025 Apr 3;52(1):359. doi: 10.1007/s11033-025-10449-8.
6
Myopenia and body fat distribution in hospitalized ulcerative colitis patients: correlations with clinical characteristics and response to vedolizumab.住院溃疡性结肠炎患者的肌肉减少症和体脂分布:与临床特征及维多珠单抗反应的相关性
Front Nutr. 2024 Dec 20;11:1411695. doi: 10.3389/fnut.2024.1411695. eCollection 2024.
7
Identification of hub programmed cell death-related genes and immune infiltration in Crohn's disease using bioinformatics.利用生物信息学鉴定克罗恩病中与程序性细胞死亡相关的关键基因及免疫浸润情况
Front Genet. 2024 Dec 18;15:1425062. doi: 10.3389/fgene.2024.1425062. eCollection 2024.
8
Exploring photobiomodulation in the management of bowel diseases: a concise critical review.探讨光生物调节在肠道疾病管理中的应用:简要的批判性综述。
Lasers Med Sci. 2024 Oct 27;39(1):265. doi: 10.1007/s10103-024-04217-6.
9
Epithelial barrier dysfunction and microbial dysbiosis: exploring the pathogenesis and therapeutic strategies for Crohn's disease.上皮屏障功能障碍与微生物群落失调:探索克罗恩病的发病机制与治疗策略
Tissue Barriers. 2024 Aug 26:2390705. doi: 10.1080/21688370.2024.2390705.
鉴定与溃疡性结肠炎相关的基因特征,并与结肠癌中的免疫浸润相关联。
Front Immunol. 2023 Jan 19;14:1086898. doi: 10.3389/fimmu.2023.1086898. eCollection 2023.
4
Identification and exploration of pharmacological pyroptosis-related biomarkers of ulcerative colitis.溃疡性结肠炎相关药物性 pyroptosis 生物学标志物的鉴定与探索。
Front Immunol. 2022 Oct 13;13:998470. doi: 10.3389/fimmu.2022.998470. eCollection 2022.
5
How to place the duality of specific MMP-9 inhibition for treatment of inflammatory bowel diseases into clinical opportunities?如何将特异性 MMP-9 抑制的双重性转化为治疗炎症性肠病的临床机会?
Front Immunol. 2022 Sep 9;13:983964. doi: 10.3389/fimmu.2022.983964. eCollection 2022.
6
The Impact of Matrix Metalloproteinase-11 Polymorphisms on Colorectal Cancer Progression and Clinicopathological Characteristics.基质金属蛋白酶-11基因多态性对结直肠癌进展及临床病理特征的影响
Diagnostics (Basel). 2022 Jul 11;12(7):1685. doi: 10.3390/diagnostics12071685.
7
The Role of Innate and Adaptive Immune Cells in the Pathogenesis and Development of the Inflammatory Response in Ulcerative Colitis.先天性和适应性免疫细胞在溃疡性结肠炎炎症反应的发病机制及发展中的作用
J Clin Med. 2022 Jan 13;11(2):400. doi: 10.3390/jcm11020400.
8
The Pathogenic Roles of IL-22 in Colitis: Its Transcription Regulation by Musculin in T Helper Subsets and Innate Lymphoid Cells.IL-22 在结肠炎中的致病作用:其在辅助性 T 细胞亚群和固有淋巴细胞中受肌动蛋白转录调控。
Front Immunol. 2021 Dec 21;12:758730. doi: 10.3389/fimmu.2021.758730. eCollection 2021.
9
Integrated Multi-Omics Investigations of Metalloproteinases in Colon Cancer: Focus on MMP2 and MMP9.结肠癌中金属蛋白酶的综合多组学研究:聚焦基质金属蛋白酶2和基质金属蛋白酶9
Int J Mol Sci. 2021 Nov 17;22(22):12389. doi: 10.3390/ijms222212389.
10
Serum matrix metalloproteinase-9 concentration as a marker of disease activity in patients with inflammatory bowel disease.血清基质金属蛋白酶-9 浓度作为炎症性肠病患者疾病活动的标志物。
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e803-e809. doi: 10.1097/MEG.0000000000002264.